224 related articles for article (PubMed ID: 20214530)
21. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
Khoshakhlagh P; Johnson R; Langguth P; Nawroth T; Schmueser L; Hellmann N; Decker H; Szekely NK
J Pharm Sci; 2015 Jul; 104(7):2213-24. PubMed ID: 25964103
[TBL] [Abstract][Full Text] [Related]
22. Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds.
Andersson SBE; Alvebratt C; Bergström CAS
Pharm Res; 2017 Sep; 34(9):1805-1816. PubMed ID: 28620887
[TBL] [Abstract][Full Text] [Related]
23. Bile Salt Micelles and Phospholipid Vesicles Present in Simulated and Human Intestinal Fluids: Structural Analysis by Flow Field-Flow Fractionation/Multiangle Laser Light Scattering.
Elvang PA; Hinna AH; Brouwers J; Hens B; Augustijns P; Brandl M
J Pharm Sci; 2016 Sep; 105(9):2832-2839. PubMed ID: 27103012
[TBL] [Abstract][Full Text] [Related]
24. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
Buckley ST; Frank KJ; Fricker G; Brandl M
Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
[TBL] [Abstract][Full Text] [Related]
25. Estimating drug solubility in the gastrointestinal tract.
Dressman JB; Vertzoni M; Goumas K; Reppas C
Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME).
Dai WG; Dong LC; Shi X; Nguyen J; Evans J; Xu Y; Creasey AA
J Pharm Sci; 2007 Nov; 96(11):2957-69. PubMed ID: 17705287
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs.
Prasad D; Gu CH; Kuldipkumar A
Pharm Dev Technol; 2016; 21(4):511-7. PubMed ID: 25703029
[TBL] [Abstract][Full Text] [Related]
28. Solubilization of poorly water-soluble drug carbamezapine in pluronic micelles: effect of molecular characteristics, temperature and added salt on the solubilizing capacity.
Kadam Y; Yerramilli U; Bahadur A
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):141-7. PubMed ID: 19403275
[TBL] [Abstract][Full Text] [Related]
29. A modified physiological BCS for prediction of intestinal absorption in drug discovery.
Zaki NM; Artursson P; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1478-87. PubMed ID: 20734997
[TBL] [Abstract][Full Text] [Related]
30. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
31. What is modulating solubility in simulated intestinal fluids?
Ottaviani G; Gosling DJ; Patissier C; Rodde S; Zhou L; Faller B
Eur J Pharm Sci; 2010 Nov; 41(3-4):452-7. PubMed ID: 20656026
[TBL] [Abstract][Full Text] [Related]
32. Nanonization strategies for poorly water-soluble drugs.
Chen H; Khemtong C; Yang X; Chang X; Gao J
Drug Discov Today; 2011 Apr; 16(7-8):354-60. PubMed ID: 20206289
[TBL] [Abstract][Full Text] [Related]
33. Efficiency of single pharmaceutical surfactants to mimic intestinal biorelevant media solubilization and dissolution of etravirine: Comparison of intrinsic and film dissolution models.
Oktay AN; Polli JE
Eur J Pharm Sci; 2024 May; 196():106746. PubMed ID: 38499112
[TBL] [Abstract][Full Text] [Related]
34. Prediction of food effect on in vitro drug dissolution into biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
Jamil R; Polli JE
Eur J Pharm Sci; 2022 Oct; 177():106274. PubMed ID: 35944878
[TBL] [Abstract][Full Text] [Related]
35. Understanding the Role of Sodium Lauryl Sulfate on the Biorelevant Solubility of a Combination of Poorly Water-Soluble Drugs Using High Throughput Experimentation and Mechanistic Absorption Modeling.
Bahr MN; Modi D; Patel S; Campbell G; Stockdale G
J Pharm Pharm Sci; 2019; 22(1):221-246. PubMed ID: 31219781
[TBL] [Abstract][Full Text] [Related]
36. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.
Lehto P; Kortejärvi H; Liimatainen A; Ojala K; Kangas H; Hirvonen J; Tanninen VP; Peltonen L
Eur J Pharm Biopharm; 2011 Aug; 78(3):531-8. PubMed ID: 21329757
[TBL] [Abstract][Full Text] [Related]
37. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
[TBL] [Abstract][Full Text] [Related]
38. Excipient-mediated supersaturation stabilization in human intestinal fluids.
Bevernage J; Forier T; Brouwers J; Tack J; Annaert P; Augustijns P
Mol Pharm; 2011 Apr; 8(2):564-70. PubMed ID: 21268663
[TBL] [Abstract][Full Text] [Related]
39. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
Wei H; Löbenberg R
Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
[TBL] [Abstract][Full Text] [Related]
40. Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound.
Frank KJ; Westedt U; Rosenblatt KM; Hölig P; Rosenberg J; Mägerlein M; Brandl M; Fricker G
Eur J Pharm Sci; 2012 Aug; 47(1):16-20. PubMed ID: 22579958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
